These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36737523)

  • 21. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD; Konsek SJ; Buscombe JR; Maciejkiewicz K; Cichocki A; Roszkowska-Purska K; Sawicki Ł; Tenderenda M; Cwikla JB
    Nucl Med Rev Cent East Eur; 2019; 22(1):1-7. PubMed ID: 30276787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.
    Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH
    Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
    Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
    Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors.
    McGovern JM; Singhi AD; Borhani AA; Furlan A; McGrath KM; Zeh HJ; Bahary N; Dasyam AK
    AJR Am J Roentgenol; 2018 Nov; 211(5):1020-1025. PubMed ID: 30160983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastroenteropancreatic endocrine tumors].
    Schmid-Tannwald C; Schmid-Tannwald CM; Reiser MF; Berger F
    Radiologe; 2014 Oct; 54(10):989-97. PubMed ID: 25234769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbidopa-assisted
    Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
    Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pancreatic neuroendocrine neoplasms].
    Beiderwellen K; Sabet A; Lauenstein TC; Lahner H; Poeppel TD
    Radiologe; 2016 Apr; 56(4):348-54. PubMed ID: 27003413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
    van Beek DJ; Pieterman CRC; Wessels FJ; van de Ven AC; de Herder WW; Dekkers OM; Zandee WT; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Front Endocrinol (Lausanne); 2022; 13():926491. PubMed ID: 36277719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of PET/CT in the Imaging of Pancreatic Neoplasms.
    Duan H; Baratto L; Iagaru A
    Semin Ultrasound CT MR; 2019 Dec; 40(6):500-508. PubMed ID: 31806148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
    De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
    World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics.
    Raman SP; Hruban RH; Cameron JL; Wolfgang CL; Fishman EK
    AJR Am J Roentgenol; 2012 Aug; 199(2):309-18. PubMed ID: 22826391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment.
    Guenter R; Aweda T; Carmona Matos DM; Jang S; Whitt J; Cheng YQ; Liu XM; Chen H; Lapi SE; Jaskula-Sztul R
    Surgery; 2020 Jan; 167(1):189-196. PubMed ID: 31629542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal strategy of systemic treatment for unresectable pancreatic neuroendocrine tumors based upon opinion of Japanese experts.
    Ikeda M; Morizane C; Hijioka S; Matsumoto S; Konishi T; Komoto I; Aoki T; Ito T; Furuse J; Sasano H; Doi R
    Pancreatology; 2020 Jul; 20(5):944-950. PubMed ID: 32565093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine tumors of the pancreas: endoscopic diagnosis.
    Patel KK; Kim MK
    Curr Opin Gastroenterol; 2008 Sep; 24(5):638-42. PubMed ID: 19122508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
    J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors.
    Deguelte S; de Mestier L; Hentic O; Cros J; Lebtahi R; Hammel P; Kianmanesh R
    J Visc Surg; 2018 Apr; 155(2):117-125. PubMed ID: 29397338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
    Baumann T; Rottenburger C; Nicolas G; Wild D
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.